Exchange: OTC·Updated 03:51 PM EDT

RLFFD Relief Therapeutics Holding SA

$0.1665
$0.0432
(20.60%)
Today
Mkt Cap$28.3M
Vol9,543.00

About RLFFD

MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
50

Neutral Sentiment

How do you feel about RLFFD?

Advertisement|Remove ads.